APA (7th ed.) Citation

NM, N., JC, L., S, B., F, D., B, B., KV, P., . . . M, P. (2024). A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): A multicentre, open-label randomised controlled trial. The lancet. Gastroenterology & hepatology, 9(5), 415. https://doi.org/10.1016/S2468-1253(24)00034-7

Chicago Style (17th ed.) Citation

NM, Noor, et al. "A Biomarker-stratified Comparison of Top-down Versus Accelerated Step-up Treatment Strategies for Patients with Newly Diagnosed Crohn's Disease (PROFILE): A Multicentre, Open-label Randomised Controlled Trial." The Lancet. Gastroenterology & Hepatology 9, no. 5 (2024): 415. https://doi.org/10.1016/S2468-1253(24)00034-7.

MLA (9th ed.) Citation

NM, Noor, et al. "A Biomarker-stratified Comparison of Top-down Versus Accelerated Step-up Treatment Strategies for Patients with Newly Diagnosed Crohn's Disease (PROFILE): A Multicentre, Open-label Randomised Controlled Trial." The Lancet. Gastroenterology & Hepatology, vol. 9, no. 5, 2024, p. 415, https://doi.org/10.1016/S2468-1253(24)00034-7.